iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by TCP Asset Management LLC

TCP Asset Management LLC lowered its position in iShares Biotechnology ETF (NASDAQ:IBB) by 24.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,544 shares of the financial services provider’s stock after selling 492 shares during the quarter. TCP Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $212,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in IBB. Future Financial Wealth Managment LLC bought a new position in iShares Biotechnology ETF in the 1st quarter valued at about $27,000. Pacifica Partners Inc. boosted its holdings in shares of iShares Biotechnology ETF by 118.2% in the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 130 shares in the last quarter. Crewe Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 78 shares during the period. Northwest Financial Advisors bought a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $42,000. Finally, Values First Advisors Inc. acquired a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $43,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.7 %

Shares of IBB stock traded down $0.93 during mid-day trading on Wednesday, hitting $135.09. 1,045,826 shares of the stock traded hands, compared to its average volume of 1,631,982. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16. The company’s 50-day simple moving average is $134.94 and its 200-day simple moving average is $134.97.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.